These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11031802)

  • 21. Treatment of substance abuse in patients with HIV infection.
    Faltz BG; Madover S
    Adv Alcohol Subst Abuse; 1987; 7(2):143-57. PubMed ID: 3482340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study.
    Olley BO; Seedat S; Stein DJ
    J Psychosom Res; 2006 Oct; 61(4):479-84. PubMed ID: 17011355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-taking behavior, substance abuse disorders, and the acquired immune deficiency syndrome.
    Flavin DK; Frances RJ
    Adv Alcohol Subst Abuse; 1987; 6(3):23-32. PubMed ID: 3661299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caring for intravenous drug abusers with HIV infection.
    Welsby PD
    Midwife Health Visit Community Nurse; 1988 Aug; 24(8):318-20. PubMed ID: 3419352
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV-risk behaviors in adolescent substance abusers.
    Deas-Nesmith D; Brady KT; White R; Campbell S
    J Subst Abuse Treat; 1999 Mar; 16(2):169-72. PubMed ID: 10023616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case management of substance abusers with HIV disease.
    Schwartz B; Dilley J; Sorensen JL
    J Case Manag; 1994; 3(4):173-8. PubMed ID: 7735090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The triple diagnosed.
    Ware PJ
    Caring; 1995 Feb; 14(2):28-30, 32-3. PubMed ID: 10172230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus prevention and the potential of drug abuse treatment.
    Metzger DS; Navaline H
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S451-6. PubMed ID: 14648463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of psychiatric disorders in patients infected with human immunodeficiency virus.
    Angelino AF; Treisman GJ
    Clin Infect Dis; 2001 Sep; 33(6):847-56. PubMed ID: 11512090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The shifting locus of risk-reduction: the critical role of HIV infected individuals.
    Indyk D; Golub SA
    Soc Work Health Care; 2006; 42(3-4):113-32. PubMed ID: 16687378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric aspects of comorbid HIV/AIDS and pain, Part 2.
    Douaihy AB; Stowell KR; Kohnen S; Stoklosa JB; Breitbart WS
    AIDS Read; 2007 Jul; 17(7):350-2, 357-61. PubMed ID: 17672014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation efforts among substance abusers with and without psychiatric comorbidity.
    Unrod M; Cook T; Myers MG; Brown SA
    Addict Behav; 2004 Jul; 29(5):1009-13. PubMed ID: 15219350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mental health research in HIV/AIDS and aging: problems and prospects.
    Stoff DM
    AIDS; 2004 Jan; 18 Suppl 1():S3-10. PubMed ID: 15075492
    [No Abstract]   [Full Text] [Related]  

  • 34. Postscript: where do we go from here?
    Sloboda Z; Stephens RC; Alemagno S
    J Psychoactive Drugs; 1998; 30(3):307-14. PubMed ID: 9798797
    [No Abstract]   [Full Text] [Related]  

  • 35. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
    Douaihy AB; Jou RJ; Gorske T; Salloum IM
    AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfection.
    Fuller BE; Loftis JM; Rodriguez VL; McQuesten MJ; Hauser P
    Curr Opin Psychiatry; 2009 Jul; 22(4):401-8. PubMed ID: 19436202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug injection cessation among HIV-infected injecting drug users.
    Bouhnik AD; Carrieri MP; Rey D; Spire B; Gastaut JA; Gallais H; Obadia Y;
    Addict Behav; 2004 Aug; 29(6):1189-97. PubMed ID: 15236822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report.
    Kopnisky KL; Bao J; Lin YW
    Brain Behav Immun; 2007 May; 21(4):428-41. PubMed ID: 17346925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.